Status:
UNKNOWN
Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women
Lead Sponsor:
Nantes University Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
40-65 years
Phase:
NA
Brief Summary
Context: In France, cervical cancer (CC) screening was opportunistic until recently. The target population includes women aged 25 to 65 years. About 66% of women aged 25-40 years have performed a scr...
Detailed Description
Design, Setting and Participants: The investigators will conduct a 3-arm, cluster-randomized, controlled trial in the Loire-Atlantique region, in France. The study will include a total of 1,500 GPs ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for GPs:
- \- All GPs practicing in the Loire-Atlantique region (Western France) will be included.
- Inclusion criteria for patients :
- women aged 40 to 65 years,
- being on the patient list of the GPs participating in the study,
- living in the Loire-Atlantique region (Western France),
- being affiliated to the National Health Insurance.
- Exclusion Criteria for GPs:
- \- GPs who could refuse to participate by contacting the research team.
- Inclusion criteria for patients :
- Refusal to participate to the study
- Female patients who underwent total hysterectomy and those who received a pathological result of a previous pap smear (asc-us or CIN) are not eligible to participate in the CC screening and therefore excluded from the study.
- Women not registered with a GP located in Loire-Atlantique will not be included.
Exclusion
Key Trial Info
Start Date :
January 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 2 2023
Estimated Enrollment :
195000 Patients enrolled
Trial Details
Trial ID
NCT04689178
Start Date
January 8 2021
End Date
December 2 2023
Last Update
February 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Nantes, France, 44000